摘要
目的探讨中医药辨证治联合FOLFOX-6辅助化疗对结肠癌患者根治术后的临床疗效。方法采用中医药辨证治联合FOLFOX-6对60例(B组)结直肠癌根治术后患者辅助化疗,与中医药辨证治联合FOLFOX-6对60例(A组)对照。结果骨髓抑制B组发生率55%,A组发生率38.5%,A组明显少于B组;A组中性粒细胞减少发生率为45.2%,B组为80%,A组中性粒细胞减少发生率明显少于B组。结论中医药辨证施治联合FOLFOX-6辅助化疗治疗根治术后结肠癌患者在提高患者对化疗的耐受性,增加化疗的疗效,减轻化疗的毒副反应,提高患者生存质量,延长生存期的治疗中发挥着积极的作用。
Objective Discuss joint syndrome differentiation of traditional Chinese medicine cure FOLFOX - 6 the clinical curative effect of adjuvant chemotherapy in patients with colon cancer radical surgery＇s Methods The syndrome differentiation of traditional Chinese medicine cure joint FOLFOX - 6 to 60 cases （group B） postoperative adjuvant chemotherapy in patients with colorectal cancer effect A radical cure, and syndrome differentiation of traditional Chinese medicine cure joint FOLFOX - 6 to 60 cases （group A）. Result Incidence of bone marrow inhibition of 55% incidence of group B, group A was 38.5%, significantly less than group B, group A The incidence of neutropenia of group A was 45.2%, B group was 80%, the incidence of neutropenia group A significantly less than group B. Conclusion Evidence-based medicine of traditional Chinese medicine combined FOLFOX - 6 cure postoperative adjuvant chemotherapy treatment in colon cancer patients to improve patients tolerance to chemotherapy, increase the curative effect of chemotherapy, reduce the side reaction of chemotherapy, improve the quality of survival, prolong the survival period of treatment plays an active role.
出处
《中国医药指南》
2013年第22期51-52,共2页
Guide of China Medicine
